Gaseotransmitters: new frontiers for translational science
- PMID: 21106939
- PMCID: PMC3038605
- DOI: 10.1126/scitranslmed.3000721
Gaseotransmitters: new frontiers for translational science
Abstract
Translational research on endogenous gaseous mediators--nitric oxide, carbon monoxide, and hydrogen sulfide--has exploded over the past decade. Drugs that modulate either the gaseous mediators themselves or their related intracellular signaling pathways are already in use in the clinics, and still more are being tested in preclinical models and clinical trials. Discussed here are the chemical and pharmacological properties that present challenges for the translation of these potentially toxic molecules.
Figures
References
-
- Furchgott RF. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA. 1996;276:1186–1188. - PubMed
-
- Ignarro LJ, editor. Nitric oxide - Biology and Pathobiology. Academic Press; 2009.
-
- Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu. Rev. Pharmacol. Toxicol. 2006;46:411–449. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
